A Study to Assess RAD011 (Cannabidiol Oral Solution) for the Treatment of Participants With Prader-Willi Syndrome

NCT05098509 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
TERMINATED
Status
4
Enrollment
INDUSTRY
Sponsor class

Stopped Due to a change in corporate priorities, this study was voluntarily terminated by the Sponsor for reasons other than safety

Conditions

Interventions

Sponsor

Radius Pharmaceuticals, Inc.